SRY mediates male-specific susceptibility to acute liver injury

SRY介导男性对急性肝损伤的特异性易感性

阅读:1

Abstract

BACKGROUND AND AIMS: Sex-determining region on the Y chromosome (SRY), a male-specific gene, can promote the development of various liver diseases including liver fibrosis, hepatocellular carcinoma. Its role in acute liver injury (ALI), however, remains elusive. Here, we aimed to investigate the effects of SRY on ALI. METHODS: We constructed hepatocyte-specific Sry-overexpressing transgenic (Sry-TG) and hepatocyte-specific Sry knockout (Sry(ΔHC)) mice and subjected them to acetaminophen (APAP) insult to determine the potential function of SRY in ALI. Multiomics analysis was used to explore the molecular mechanisms through which SRY affects ALI. RESULTS: SRY expression was markedly upregulated in the livers of both male patients and mice with ALI. Sry-TG mice exhibited significantly exacerbated liver injury and increased apoptosis and oxidative stress. In contrast, the male Sry(ΔHC) mice exhibited a protective phenotype. Mechanistically, RNA-seq revealed that Gstm2/3 expression was downregulated in the hepatocytes of Sry-TG mice. Liquid chromatography-tandem mass spectrometry revealed PARP-1 as a candidate protein that interacts with SRY. SRY enhances the nuclear accumulation of PARP-1. PARP-1, in turn, suppresses Gstm2/3 mRNA expression by PARylating C/EBPβ and inhibiting the C/EBPβ-mediated transcriptional activation of Gstm2/3. Finally, virtual screening of compounds revealed that dutasteride can bind to SRY. Experiments revealed that dutasteride inhibits SRY expression and attenuates acute liver injury. CONCLUSIONS: Our results suggest that greater SRY expression in males may account for the susceptibility of males ALI. Dutasteride binds specifically to SRY and inhibits its expression, making it a promising therapy for the clinical treatment of ALI.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。